Complete endoscopic remission is not only associated with higher mucosal concentrations of 5-aminosalicylic acid but also with N-acetyl-5-aminosalicylic acid in patients with ulcerative colitis

被引:0
|
作者
Fukuda, T. [1 ]
Naganuma, M. [1 ]
Takabayashi, K. [2 ]
Hagihara, Y. [1 ]
Tanemoto, S. [1 ]
Nomura, E. [1 ]
Yoshimatsu, Y. [1 ]
Sugimoto, S. [1 ]
Nanki, K. [1 ]
Mizuno, S. [1 ]
Mikami, Y. [1 ]
Fukuhara, K. [3 ]
Suzino, T. [1 ]
Mutaguchi, M. [2 ]
Inoue, N. [3 ]
Ogata, H. [2 ]
Iwao, Y. [3 ]
Kanai, T. [1 ]
机构
[1] Keio Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan
[2] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan
[3] Keio Univ, Sch Med, Ctr Prevent Med, Tokyo, Japan
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P630
引用
收藏
页码:S522 / S523
页数:2
相关论文
共 50 条
  • [41] Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
    Matsumoto, Hiroshi
    Sasahira, Momoyo
    Go, Tei Tei
    Yo, Shogen
    Ninomiya, Takehiro
    Osawa, Motoyasu
    Handa, Osamu
    Umegami, Eiji
    Inoue, Ryo
    Shiotani, Akiko
    BIOMEDICINES, 2024, 12 (09)
  • [42] Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis
    Yamamoto, Yuki
    Masuda, Satohiro
    Nakase, Hiroshi
    Matsuura, Minoru
    Maruyama, Shihoko
    Hisamatsu, Tadakazu
    Suzuki, Yasuo
    Matsubara, Kazuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (01) : 81 - 86
  • [43] DISPOSITION OF 5-AMINOSALICYLIC ACID (5-ASA) BY DIPENTUM AND ASACOL IN PATIENTS WITH ULCERATIVE-COLITIS (UC) IN REMISSION
    GIONCHETTI, P
    CAMPIERI, M
    FERRETTI, M
    BELLUZZI, A
    RIZZELLO, F
    VENTURI, A
    BRIGNOLA, C
    MIGLIOLI, M
    BARBARA, L
    GASTROENTEROLOGY, 1995, 108 (04) : A823 - A823
  • [44] Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
    Mikami, Yohei
    Tsunoda, Junya
    Suzuki, Shohei
    Mizushima, Ichiro
    Kiyohara, Hiroki
    Kanai, Takanori
    DIGESTION, 2023, 104 (01) : 58 - 65
  • [45] Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
    Yan, Yan
    Ren, Fengling
    Wang, Pengchong
    Sun, Ying
    Xing, Jianfeng
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (12) : 1452 - 1461
  • [46] INTERMITTENT VERSUS CONTINUOUS 5-AMINOSALICYLIC ACID TREATMENT FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS
    BARDAZZI, G
    DALBASIO, G
    BONANOMI, AG
    TRALLORI, G
    MESSORI, A
    AMOROSI, A
    BARTOLETTI, L
    MORETTINI, A
    PACINI, F
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1994, 26 (07): : 334 - 337
  • [47] The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
    He, Long
    Wen, Shuting
    Zhong, Zhuotai
    Weng, Senhui
    Jiang, Qilong
    Mi, Hong
    Liu, Fengbin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] 5-AMINOSALICYLIC ACID IN ULCERATIVE-COLITIS AND CROHNS-DISEASE
    MAIER, K
    FISCHER, C
    KLOTZ, U
    HEINKEL, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (29-3) : 1131 - 1134
  • [49] Evaluating the effects of 5-aminosalicylic acid on tofacitinib treatment in ulcerative colitis
    Nishida, Yu
    Hosomi, Shuhei
    Fujimoto, Koji
    Kobayashi, Yumie
    Nakata, Rieko
    Maruyama, Hirotsugu
    Ominami, Masaki
    Nadatani, Yuji
    Fukunaga, Shusei
    Otani, Koji
    Tanaka, Fumio
    Fujiwara, Yasuhiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (01) : 108 - 114
  • [50] 5-AMINOSALICYLIC ACID AS ENEMAS OR SUPPOSITORIES IN DISTAL ULCERATIVE-COLITIS
    CAMPIERI, M
    GIONCHETTI, P
    BELLUZZI, A
    BRIGNOLA, C
    TABANELLI, GM
    MIGLIOLI, M
    BARBARA, L
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (04) : 406 - 409